Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
IMRX Immuneering
4.090
+0.210+5.41%
Post Mkt Price
4.0900.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Investing cash flow
Cash flow from continuing investing activities
98.33% -880.08K 111,852.97% 22.15M 74,990.38% 12.4M -141,463.17% -75.62M
Net PPE purchase and sale
-3,364.96% -393.13K -732.31% -165K -594.58% -115.05K -13.80% -60.79K
Net business purchase and sale
-- -- -- -- -- -- -- 70.35K
Net investment purchase and sale
-- -486.94K -- 22.32M -- 12.52M -- -75.63M
Cash from discontinued investing activities
Investing cash flow
98.33% -880.08K 111,852.97% 22.15M 74,990.38% 12.4M -141,463.17% -75.62M
Financing cash flow
Cash flow from continuing financing activities
-100.01% -17.21K -99.89% 27.78K 193.11K 279.82% 144.26M
Net common stock issuance
-- -- -- -- -- -- -- 120.32M
Net preferred stock issuance
-- 0 -- -- -- -- -34.74% 24.79M
Proceeds from stock option exercised by employees
-87.30% 37.39K -- 27.78K -- 193.11K -- 1.28M
Net other financing activities
-- -- -- -- -- -- -- -2.12M
Cash from discontinued financing activities
Financing cash flow
-100.01% -17.21K -99.89% 27.78K -- 193.11K 279.82% 144.26M
Net cash flow
Beginning cash position
75.02% 87.94M 143.12% 75.21M 101.91% 74.89M 169.12% 37.09M
Current changes in cash
-120.32% -11.52M -34.07% 12.73M 105.15% 316.92K 62.17% 37.8M
End cash Position
-28.53% 76.42M 75.02% 87.94M 143.12% 75.21M 101.91% 74.89M
Free cash flow
-21.77% -11.02M -48.89% -9.61M -101.35% -12.4M -110.65% -30.91M
Investing cash flow
Cash flow from continuing investing activities
98.33% -880.08K 111,852.97% 22.15M 74,990.38% 12.4M -141,463.17% -75.62M
Net PPE purchase and sale
-3,364.96% -393.13K -732.31% -165K -594.58% -115.05K -13.80% -60.79K
Net business purchase and sale
-- -- -- -- -- -- -- 70.35K
Net investment purchase and sale
-- -486.94K -- 22.32M -- 12.52M -- -75.63M
Cash from discontinued investing activities
Investing cash flow
98.33% -880.08K 111,852.97% 22.15M 74,990.38% 12.4M -141,463.17% -75.62M
Financing cash flow
Cash flow from continuing financing activities
-100.01% -17.21K -99.89% 27.78K 193.11K 279.82% 144.26M
Net common stock issuance
-- -- -- -- -- -- -- 120.32M
Net preferred stock issuance
-- 0 -- -- -- -- -34.74% 24.79M
Proceeds from stock option exercised by employees
-87.30% 37.39K -- 27.78K -- 193.11K -- 1.28M
Net other financing activities
-- -- -- -- -- -- -- -2.12M
Cash from discontinued financing activities
Financing cash flow
-100.01% -17.21K -99.89% 27.78K -- 193.11K 279.82% 144.26M
Net cash flow
Beginning cash position
75.02% 87.94M 143.12% 75.21M 101.91% 74.89M 169.12% 37.09M
Current changes in cash
-120.32% -11.52M -34.07% 12.73M 105.15% 316.92K 62.17% 37.8M
End cash Position
-28.53% 76.42M 75.02% 87.94M 143.12% 75.21M 101.91% 74.89M
Free cash flow
-21.77% -11.02M -48.89% -9.61M -101.35% -12.4M -110.65% -30.91M
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
CEO: Dr. Benjamin J. Zeskind, PhD
Market: NASDAQ
Listing Date: 07/30/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist